[Hepatitides following narcotics and hallucinogens].
D000328:Adult; D000661:Amphetamine / Q000506:poisoning; D002188:Cannabis / Q000506:poisoning*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006511:Hepatitis B Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000032:analysis; D006801:Humans; D007275:Injections, Intravenous; D008111:Liver Function Tests; D008238:Lysergic Acid Diethylamide / Q000506:poisoning*; D008297:Male; D008635:Mescaline / Q000506:poisoning; D009892:Opium / Q000506:poisoning; D019966:Substance-Related Disorders
D006511:Hepatitis B Antigens; D009892:Opium; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D008635:Mescaline
Hepatitiden nach Gebrauch von Rauschfift und Halluzinogenen.